價(jià)格 | ¥10600 | ¥17500 | ¥13800 |
包裝 | 25mg | 100mg | 50mg |
最小起訂量 | 1mg |
發(fā)貨地 | 上海 |
更新日期 | 2024-12-02 |
中文名稱(chēng):化合物 Anticancer agent 47 | 英文名稱(chēng):Anticancer agent 47 |
CAS:2461795-23-1 | 品牌: TargetMol |
產(chǎn)地: 美國(guó) | 保存條件: Shipping with blue ice. |
產(chǎn)品類(lèi)別: 抑制劑 | |
貨號(hào): T61412 |
名稱(chēng) | Anticancer agent 47 |
描述 | Anticancer agent 47 (compound 4j) exhibits potent anticancer properties, demonstrating antiproliferative activities and inducing apoptosis as well as cell cycle arrest at G0/G1 phase. Moreover, Anticancer agent 47 has exhibited significant in vivo antitumor activities [1]. |
體外活性 | Anticancer agent 47 (compound 4j) shows antiproliferative activities with IC 50 s of 1.6, 0.72, 7.07 μM for HepG2, A549, H596 cells, respectively [1]. Anticancer agent 47 (0.8, 1.6, 3.2 μM; 24 h) induces apoptosis and cell cycle arrest at G0/G1 phase [1]. Anticancer agent 47 (5 μM; 5h) significantly increases ROS production [1]. Apoptosis Analysis [1] Cell Line: HepG2, H596 cells Concentration: 0.8, 1.6, 3.2 μM Incubation Time: 24 h Result: Induced apoptosis with the apoptotic cell rates were 14.23, 20.47 and 27.66% at 0.8, 1.6, 3.2 μM in HepG2 cell, respectively. Cell Cycle Analysis [1] Cell Line: HepG2 cells Concentration: 0.8, 1.6, 3.2 μM Incubation Time: 24 h Result: Showed 48.54%, 49.60% and 53.00% cells were at G0/G1 phase at 0.6, 1.2 and 2.4 μM, respectively. |
體內(nèi)活性 | Anticancer agent 47 (20 mg/kg; i.v.; once every 2 days for 19 days) shows antitumor activities [1]. Animal Model: BALB/c nude mice (HepG2 xenografts) [1] Dosage: 20 mg/kg Administration: I.v.; once every 2 days for 19 days Result: Effectively inhibited tumor growth with the 58.7% tumor inhibition rate. |
存儲(chǔ)條件 | Shipping with blue ice. |
成立日期 | 2013-04-18 (12年) | 注冊(cè)資本 | 589.8595萬(wàn)人民幣 |
員工人數(shù) | 100-500人 | 年?duì)I業(yè)額 | ¥ 1億以上 |
主營(yíng)行業(yè) | 中間體,天然產(chǎn)物,生物化工,化學(xué)試劑,生物技術(shù)服務(wù) | 經(jīng)營(yíng)模式 | 貿(mào)易,工廠,試劑,定制,服務(wù) |
產(chǎn)品名稱(chēng) | 價(jià)格 | 公司名稱(chēng) | 報(bào)價(jià)日期 | |
---|---|---|---|---|
詢(xún)價(jià) |
VIP1年
|
陜西格列弗生物科技研究有限責(zé)任公司
|
2024-12-27 | |
詢(xún)價(jià) |
VIP3年
|
陜西締都新材料有限公司
|
2024-12-18 | |
詢(xún)價(jià) |
VIP1年
|
青島愷潤(rùn)生物醫(yī)藥科技有限公司
|
2024-11-02 |